Navigation Links
Six Abstracts Featuring Exelixis Compounds Accepted At ASCO,Conference

- Phase I data from XL880, Phase II data from XL999 studies scheduled for presentation during oral, poster sessions -

SOUTH SAN FRANCISCO, May 30, 2007 /PRNewswire-FirstCall/ -- Exelixis, Inc. announced today that data from clinical trials of the company's investigational compounds XL880 and XL999 will be presented at the 2007 American Society of Clinical Oncology Annual Meeting (ASCO), which is being held June 1 to 5 in Chicago, Illinois.

    -- Data from the Phase I trials of XL880 will be presented and discussed

       during the Developmental Therapeutics: Molecular Therapeutics oral

       abstract presentation session at 9:00 a.m. CT on Saturday, June 2, in

       room E354b. (Abstract #3526)


    -- Data from the Phase II trials of XL999 will be presented and discussed

       during the Developmental Therapeutics: Molecular Therapeutics poster

       session at 8:00 a.m. on Sunday, June 3, in S Hall A2. (Abstract #3591)


Additionally, four abstracts from Phase I studies of XL184 (Abstract #14031), XL647 (Abstract #14044) and Phase II studies of XL880 (Abstract #15601) and XL999 (Abstract #18112) will be published in abstract form but will not be presented at the meeting.

About Exelixis

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. The company is leveraging its fully integrated drug discovery platform to fuel the growth of its development pipeline, which is primarily focused on cancer. Currently, Exelixis' broad product pipeline includes investigational compounds in Phase II and Phase I clinical development for cancer and renal disease. Exelixis has established strategic corporate alliances with major pharmaceutical and biotechnology companies, including GlaxoSmithKline, Bristol-Myers Squibb Company, Genentech, Wyeth
'"/>




Page: 1 2

Related medicine technology :

1. Savient Pharmaceuticals Announces Acceptance of Two Gout-Related Abstracts for Poster Presentation at the European League Against Rheumatism (EULAR) 2007 Annual Congress
2. OXiGENE Abstracts Published in ASCO Program
3. Genta Incorporated to Present Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
4. Pharmacyclics Announces Presentations and Published Abstracts on Xcytrin at The 2007 American Society of Clinical Oncology Annual Meeting
5. SciClone Announces ZADAXIN and SCV-07 Abstracts Accepted at ASCO
6. ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds for Solid Tumors Are to be Reported at ASCO
7. Pharmacyclics Announces Presentations on Its Novel and Selective HDAC and Brutons Tyrosine Kinase Inhibitor Compounds
8. Scientific Results Presented At ECCMID Demonstrate Well- Differentiated Profile of Basileas Two Phase III Anti- infective Compounds
9. EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds
10. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
11. Bentley Late Breaking Abstract Accepted for Poster Presentation at American Diabetes Association Scientific Sessions
Post Your Comments:
(Date:12/24/2014)... DIEGO , Dec. 24, 2014  Conkwest, ... West, developing the proprietary Natural Killer (NK) cell-line ... that Dr. Patrick Soon-Shiong , NantWorks founder, ... a definitive agreement to purchase approximately $48 million ... connection with the investment, he will be named ...
(Date:12/24/2014)... 23, 2014 PuraMed BioScience®, Inc., (OTC Pink: ... medicinal and healthcare products, announced it received the initial ... hemp-based, advanced headache relief product, for planned distribution to ... Colorado , Washington State , ... the MigraPure H Advanced headache relief gel formulation completed, ...
(Date:12/24/2014)... , December 24, 2014 ... Report on Global Disposable Syringe Industry of ... its online business intelligence library. ... Disposable Syringe Industry is a professional and ... market.  For overview analysis, the report introduces ...
Breaking Medicine Technology:Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5
... Athletes Who Have UCL Reconstruction Prior to Being Drafted ... Feb. 28 New research presented at ... Day in Las Vegas suggests that elbow ulnar collateral ... League Baseball (MLB) draft does not increase the risk ...
... -- MannKind Corporation (Nasdaq: MNKD ... new drug application ("NDA") for AFRESA(R), an ultra rapid-acting insulin ... announced, our internal goal was to submit the NDA to ... February. Based on editorial decisions made during the final ...
Cached Medicine Technology:Elbow Ligament Reconstruction Appears Not to Affect Future Professional Advancement in Baseball 2MannKind Updates Status of NDA Submission for AFRESA 2MannKind Updates Status of NDA Submission for AFRESA 3
(Date:12/25/2014)... December 25, 2014 When head lice hits ... in a frenzy to get rid of it while keeping ... in Coral Gables now have the solution right in their ... clinic location, Lice Troopers provides full spectrum head lice screening ... Gable area, including Sunset, Key Biscayne, Brickell, Coconut Grove, Kendall, ...
(Date:12/25/2014)... -- Among early stage breast cancer patients who undergo ... percent will eventually develop leukemia as a result of ... comes from a review of more than 20,000 breast ... suggests that the risk for developing treatment-related leukemia, though ... "The frequency of bone marrow cancers such as ...
(Date:12/25/2014)... California (PRWEB) December 25, 2014 Plugin ... of ProFire 5k. A fully customizable business presentation tool ... , “Adding the ProFire 5k business tool, users can ... Christina Austin, CEO of Pixel Film Studios. “ProFire 5k ... and style to add professionalism to a presentation” , ...
(Date:12/24/2014)... Over 700 toys, that’s what ... That is 700 smiling little faces this holiday that ... $6000 in monetary donations was given to the various ... expenses they incur through the year. Some of the ... Child's Haven , Shrine's Children's Hospitals, Toys for Tots ...
(Date:12/24/2014)... 24, 2014 New studies reveal that women ... loss related depression (March 6, 2014, JAMA Otolaryngology*). And although ... loss (about 50 percent according to recent polls) facing hearing ... how a person feels and relates to the world. People ... are also made by way of:, , ...
Breaking Medicine News(10 mins):Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:AlignLife Donates Over 700 Toys This Year 2Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 2Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 3Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 4Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 5Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 6
... , , , ... regulations take effect under the HITECH Act. HIPAA-covered entities, ... notify affected individuals, the Secretary of Health and Human Services ... information (PHI) is breached. With these new rules in ...
... Researchers have shown for the first time that patterns of ... cancer has started to spread in melanoma patients, and to ... much surgery, if any, is required and to predict the ... cancer congress, ECCO 15 ESMO 34 [1], in Berlin ...
... ... Home Training and Consulting Inc., an industry leader in Continuous Process Improvement ... Sigma Yellow Belt Course available for free. This will help thousands of ... also allow potential Lean Six Sigma Green Belt and Black Belt Candidates ...
... ... Software environment with Strategic,s validation toolkit , ... Cardiff-by-the-Sea, Calif. (PRWEB) September 23, 2009 -- Strategic Information ... solutions, today announced an expanded Alliance relationship with QAD Inc (Nasdaq: QADI), ...
... NEW YORK, Sept. 23 Grammy Award-winning singer-songwriter John Legend ... Nikki Beach Midtown for Project Sunshine,s fall fundraiser to benefit children ... 48" x 32" mixed media portrait of the singer that was ... charity. , , (Photo: ...
... , , IRVINE, Calif., Sept. ... Maggots(TM) in the United States, announced today that its Laboratory ... Limb Salvage conference in Washington, DC, from September 24 to ... the company,s Medical Maggots(TM) product (disinfected Phaenicia sericata ...
Cached Medicine News:Health News:Healthcare Breach Notification Rules Take Effect; ID Experts Offers Complimentary Tool to Measure Organizations' Breach Index 2Health News:Healthcare Breach Notification Rules Take Effect; ID Experts Offers Complimentary Tool to Measure Organizations' Breach Index 3Health News:Ultrasound can predict tumor burden and survival in melanoma patients 2Health News:Ultrasound can predict tumor burden and survival in melanoma patients 3Health News:Mountain Home Helps Companies Battle Tough Economic Times by Offering Free Lean Six Sigma Training 2Health News:Strategic Information Group Announces QAD Enterprise Validation Partnership 2Health News:Strategic Information Group Announces QAD Enterprise Validation Partnership 3Health News:Monarch Labs to Demonstrate Maggot Therapy at Diabetic Limb Salvage Conference 2Health News:Monarch Labs to Demonstrate Maggot Therapy at Diabetic Limb Salvage Conference 3
... present with fever, sore throat, ... symptoms common with a viral ... able to distinguish these from ... is the one-step antibody test ...
... urine/serum combo test that you can rely ... faster results at the point-of-care ICON ... hCG is a rapid test for detecting ... technology to selectively detect elevated levels of ...
AUTION ELEVEN is the eleventh model of AUTION series which is ideal for use in small-to-medium-sized hospitals and clinics with its smart design and features....
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Medicine Products: